SEARO n/a AMR n/a n/a n/a n/a n/a n/a n/a (SEARO surveillance National and Regional System20) supranational (regional) networks ECDC190 27 EU Current AMR Publicly Organism Hospital Susceptibility S. pneumoniae n/a ECDC member surveillance funded tests of bacteria S. aureus website; (formerly countries, (European (coordinated pathogens E. faecalis annual Iceland and reference and funded by isolated from E. faecium reports Norway data for ECDC since people with E. coli (900 public AMR) 2010) invasive K. pneumoniae health labs infections (blood P. aeruginosa serving over culture, 1400 cerebrospinal hospitals) fluid only) ESAC-Net 27 EU Current Monitoring Publicly Community and Point prevalence Antibacterials, n/a WHO ATC – 185 member antimicrobial funded hospital settings surveys in antimycotics DDD/1000 countries, usage (coordinated European acute and antivirals inhabitants Iceland and (European and funded by care hospitals; for systemic and per day, Norway reference ECDC project in use; no. (multiple data for since 2011) care public health prevalence facilities (plus a few labs serving data) denominator antimicrobials inhabitants over a variety data from outside WHO and per day; of hospitals) ATC group J) ECDC reports website; annual reports
SEARO (SEARO National and Regional System20) n/a AMR surveillance n/a n/a n/a n/a n/a n/a n/a supranational (regional) networks ECDC190 (formerly 27 EU member countries, Iceland and Norway (900 public health labs serving over 1400 hospitals) Current AMR surveillance (European reference data for AMR) Publicly funded (coordinated and funded by ECDC since 2010) Organism Hospital Susceptibility tests of bacteria pathogens isolated from people with invasive infections (blood culture, cerebrospinal fluid only) S. pneumoniae S. aureus E. faecalis E. faecium E. coli K. pneumoniae P. aeruginosa n/a ECDC website; annual reports ESAC-Net 185 27 EU member countries, Iceland and Norway (multiple public health labs serving over a variety of hospitals) Current Monitoring antimicrobial usage (European reference data for prevalence data) Publicly funded (coordinated and funded by ECDC since 2011) – Community and hospital settings Point prevalence surveys in European acute care hospitals; project in care facilities denominator data from reports Antibacterials, antimycotics and antivirals for systemic use; (plus a few antimicrobials outside WHO ATC group J) n/a WHO ATC DDD/1000 inhabitants and per day, no. inhabitants and per day; ECDC website; annual reports